Provided by Tiger Fintech (Singapore) Pte. Ltd.

Mira Pharma

1.21
-0.0100-0.82%
Volume:52.20K
Turnover:62.62K
Market Cap:20.47M
PE:-2.43
High:1.22
Open:1.22
Low:1.18
Close:1.22
Loading ...
May 13, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 01, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 13, 2024

Major Issues Report

Form 8-K - Current report
Mar 07, 2024

Major Issues Report

Form 8-K - Current report
Jan 17, 2024

Major Issues Report

Form 8-K - Current report
Dec 27, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Dec 22, 2023

Correspondence

Form CORRESP - Correspondence
Dec 19, 2023

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Dec 01, 2023

Major Issues Report

Form 8-K - Current report
Nov 20, 2023

Major Issues Report

Form 8-K - Current report
Nov 20, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Nov 14, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 26, 2023

Major Issues Report

Form 8-K - Current report
Oct 13, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Sep 16, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Sep 01, 2023

Major Issues Report

Form 8-K - Current report
Aug 14, 2023

Beneficial Ownership Change

Form SC 13D - General statement of acquisition of beneficial ownership
Aug 08, 2023

Major Issues Report

Form 8-K - Current report
Jul 31, 2023

Correspondence

Form CORRESP - Correspondence
Jul 31, 2023

Correspondence

Form CORRESP - Correspondence